ChinaCureLinkJul 1410 min readBlogCancer Treatment in China: The Complete Guide for International Patients (2026)
ChinaCureLinkJun 2910 min readBlogCAR-T Therapy in China for Australian Patients: 7 Critical Facts That Could Change Your Treatment Decision in 2026
ChinaCureLinkJun 2413 min readBlogMultiple Myeloma in China 2026: Domestic BCMA CAR-T Delivers 64% 12-Month PFS
ChinaCureLinkJun 249 min readCasesRelapsed T-Cell Leukemia, CD7 CAR-T Therapy, and a Second Chance in China
ChinaCureLinkJun 2312 min readBlogIs China Effective at Treating Leukemia? Domestic CAR-T Reaches Up to 92% Response in Refractory B-ALL
ChinaCureLinkJun 2312 min readBlog2026 Breakthrough: China's CAR-T for Advanced Lymphoma Reaches 79%+ Response Rate
ChinaCureLinkJun 2210 min readCasesDual-Target CAR-T Cell Therapy for Refractory and Relapsed Burkitt Lymphoma: A Five-Year Survival Case Study in China
ChinaCureLinkJun 1910 min readCasesNine Years, One Leap: How Multiple Myeloma Led an Italian Woman to CAR-T Therapy in China
ChinaCureLinkMay 256 min readBlogCAR-T Therapy in China 2026: Complete Treatment Guide, Costs & Top Options
ChinaCureLinkMay 206 min readBlogCAR-T Therapy Cost in China for Lymphoma (2026 Guide for International Patients)
ChinaCureLinkMay 196 min readBlogPediatric CAR-T Treatment Cost in China (2026): A Practical Guide for International Families
ChinaCureLinkMay 158 min readBlogHow to Get CAR-T in China: A Step-by-Step Access Guide for International Patients (2026)
ChinaCureLinkMay 149 min readAdvancesFDA Approved CAR-T Cell Therapy in 2026: Products, Advantages, and Costs Compared
ChinaCureLinkMay 1311 min readAdvancesCAR-T Cell Therapy Price 2026: A Global Cost Breakdown for Patients and Families
ChinaCureLinkMay 113 min readBlogIs My Child Eligible for CAR-T Therapy? The Complete Parent's Checklist for Pediatric CAR-T Eligibility